hSMG-1 inhibitor 11j
Based on 14 publication(s) in Google Scholar
hSMG-1 inhibitor 11j, a pyrimidine derivative, is a potent and selective inhibitor of hSMG-1, with an IC50 of 0.11 nM. hSMG-1 inhibitor 11j exhibits >455-fold selectivity for hSMG-1 over mTOR (IC50=50 nM), PI3Kα/γ (IC50=92/60 nM) and CDK1/CDK2 (IC50=32/7.1 μM). hSMG-1 inhibitor 11j can be used for the research of cancer.
For research use only. We do not sell to patients.
- Purity: 99.82%
- CAS No.: 1402452-15-6
- Formula: C27H28ClN7O3S
- Molecular Weight:566.07
-
Storage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications Citing Use of MedChemExpress (MCE) hSMG-1 inhibitor 11j
More- Cell. 2026 Apr 2;189(7):2024-2039.e25. [Abstract]
- Nat Methods. 2025 Jun;22(6):1237-1246. [Abstract]
- Nat Commun. 2025 Jul 1;16(1):5828. [Abstract]
- Nat Commun. 2023 Aug 8;14(1):4760. [Abstract]
- EMBO J. 2024 Oct;43(20):4752-4785. [Abstract]
- Cell Rep. 2025 Jul 17;44(8):115985. [Abstract]
- Pharm Biol. 2025 Dec;63(1):645-662. [Abstract]
- HGG Adv. 2025 Nov 6;7(1):100543. [Abstract]
- bioRxiv. 2025 Dec 23:2025.12.20.695734. [Abstract]
- bioRxiv. 2025 Nov 24:2025.11.21.689833. [Abstract]
- bioRxiv. 2025 June 02.
- bioRxiv. 2025 May 14:2025.05.09.652687. [Abstract]
- Humboldt University of Berlin. 2025.
- University of Colorado Denver. 2024.
-
RT-PCR
-
RT-PCR
-
Gel Electrophoresis
-
Cell Imaging/Staining
-
Gel Electrophoresis
Biological Activity
|
hSMG-1 0.11 nM (IC50) |
mTOR 50 nM (IC50) |
PI3Kγ 60 nM (IC50) |
PI3Kα 92 nM (IC50) |
GSKα 260 (IC50) |
GSKβ 330 (IC50) |
CDK2 7.1 μM (IC50) |
CDK1 32 μM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | IC50 |
0.00011 μM
Compound: 11j
|
Inhibition of human recombinant SMG1 expressed in HEK293 cells using GST-tagged p53 as substrate after 1 hr by DELFIA assay
Inhibition of human recombinant SMG1 expressed in HEK293 cells using GST-tagged p53 as substrate after 1 hr by DELFIA assay
|
[PMID: 23021994] |
| HEK293 | IC50 |
0.11 nM
Compound: 11j
|
Inhibition of human recombinant SMG1 expressed in HEK293 cells using GST-tagged p53 as substrate after 1 hr by DELFIA assay
Inhibition of human recombinant SMG1 expressed in HEK293 cells using GST-tagged p53 as substrate after 1 hr by DELFIA assay
|
[PMID: 23021994] |
| MDA-MB-468 | IC50 |
75 nM
Compound: 11j
|
Cytotoxicity against human MDA-MB-468 cells
Cytotoxicity against human MDA-MB-468 cells
|
[PMID: 23021994] |
hSMG-1 inhibitor 11j (0.3-3 μM; 6 h) significantly reduces UPF1 phosphorylation at 0.3 μM, and eliminates it at 1 μM in MDA 361 cells[1].
hSMG-1 inhibitor 11j inhibits MDA468 cell proliferation, with an IC50 of 75 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1402452-15-6
-
Appearance Solid
-
Molecular Weight 566.07
-
Formula C27H28ClN7O3S
-
Color White to yellow
-
SMILES
O=S(C1=CC(NC2=NC=CC(C3=CC(C4=CC=C(NC(NC)=O)C=C4)=NC=C3)=N2)=CC=C1Cl)(N(CC)CC)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (14)
-
Journal Impact Factor
-
Most Recent
-
Cell
2026 Apr 2;189(7):2024-2039.e25. PMID: 41747727 -
Nat Methods
Decoding post-transcriptional regulatory networks by RNA-linked CRISPR screening in human cells. [Abstract]2025 Jun;22(6):1237-1246. PMID: 40442371 -
Nat Commun
2025 Jul 1;16(1):5828. PMID: 40593665
hSMG-1 inhibitor 11j purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Jul 1;16(1):5828. [Abstract]
Violin plot comparing the expression changes of NMD transcripts across different groups of m6A levels in DMSO and hSMG-1 inhibitor 11j (SMG1i) (300 nM; 4 h) treated HEK293T cells.
hSMG-1 inhibitor 11j purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Jul 1;16(1):5828. [Abstract]
Comparing the expression changes for misprocessed isoforms with their counterpart protein-coding transcripts, respectively, in DMSO and hSMG-1 inhibitor 11j (SMG1i, 300 nM; 4 h) treated HEK293T cells. The results demonstrate that inhibiting SMG1 using the hSMG-1 inhibitor 11j (SMG1i) selectively blocks the NMD pathway.
-
Nat Commun
2023 Aug 8;14(1):4760. PMID: 37553321
hSMG-1 inhibitor 11j purchased from MedChemExpress. Usage Cited in: Nat Commun. 2023 Aug 8;14(1):4760. [Abstract]
Elevated transcript expression levels of two PTC-containing transcript isoforms of TP53 upon NMD inhibition by hSMG-1 inhibitor 11j (SMG1i, 300 nM, 4 h) in HCC1599 cells, as indicated by RT-PCR analysis. The 689-bpproduct corresponds to the predominant novel transcript isoform containing a retained intron, while the 170-bpproduct corresponds to a second, minor novel transcript isoform using a novel 3’ splice site. GAPDH was usedas the loading control for RT-PCR. Western blot analysis of phosphorylated UPF1 (pUPF1) was used to measureNMD activity, and β-actin was used as the loading control for Western blot. Each RT-PCR or Western blot wasrepeated twice and yielded consistent results.
-
EMBO J
2024 Oct;43(20):4752-4785. PMID: 39256562 -
Cell Rep
2025 Jul 17;44(8):115985. PMID: 40682778
hSMG-1 inhibitor 11j purchased from MedChemExpress. Usage Cited in: Cell Rep. 2025 Jul 17;44(8):115985. [Abstract]
Agarose gels of RT-PCR products for PEs in DHX9, RPS9, TRA2A, SRSF2, and SRSF6 in A704 cells treated with DMSO, mTORi, or hSMG-1 inhibitor 11j (SMG1i, 300 nM; 24 h), each with quantification of three biological replicates.
-
Pharm Biol
The natural statin α,β-dehydromonacolin K exerts anti-secretory effect in human intestinal epithelial cells via a nonsense-mediated mRNA decay-dependent mechanism. [Abstract]2025 Dec;63(1):645-662. PMID: 40847532
hSMG-1 inhibitor 11j purchased from MedChemExpress. Usage Cited in: Pharm Biol. 2025 Dec;63(1):645-662. [Abstract]
Bright field images of human colonoids were taken after exposure to the indicated treatments, with observations made at 0 and 2 h following forskolin treatment. Colonoids were pre-treated for an hour with α,β-dehydromonacolin K (20 µM) with or without hSMG-1 inhibitor 11j (SMG1i) (1 µM) (scale bar = 500 µm). The results showed that the inhibitory effect of α,β-dehydromonacolin K on forskolin-induced fluid secretion was significantly diminished in the presence of the SMG1 inhibitor (hSMG-1 inhibitor 11j (SMG1i)).
-
HGG Adv
Exon-skipping due to bi-allelic splice site mutations in the neurodevelopmental disease gene LNPK. [Abstract]2025 Nov 6;7(1):100543. PMID: 41204669 -
bioRxiv
Genomic stop codon scanning reveals quantitative principles of nonsense-mediated mRNA decay. [Abstract]2025 Dec 23:2025.12.20.695734. PMID: 41509423 -
bioRxiv
TDP-43 suppression of ATP8A2 cryptic splicing implicates phosphatidylserine-driven neuroinflammation in ALS/FTD. [Abstract]2025 Nov 24:2025.11.21.689833. PMID: 41394670 -
-
bioRxiv
2025 May 14:2025.05.09.652687. PMID: 40463124 -
-
Solvent & Solubility
DMSO : 80 mg/mL (141.33 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 6 mg/mL (10.60 mM); Clear solution
This protocol yields a clear solution of ≥ 6 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (60.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.7666 mL | 8.8328 mL | 17.6657 mL | 44.1641 mL |
| 5 mM | 0.3533 mL | 1.7666 mL | 3.5331 mL | 8.8328 mL | |
| 10 mM | 0.1767 mL | 0.8833 mL | 1.7666 mL | 4.4164 mL | |
| 15 mM | 0.1178 mL | 0.5889 mL | 1.1777 mL | 2.9443 mL | |
| 20 mM | 0.0883 mL | 0.4416 mL | 0.8833 mL | 2.2082 mL | |
| 25 mM | 0.0707 mL | 0.3533 mL | 0.7066 mL | 1.7666 mL | |
| 30 mM | 0.0589 mL | 0.2944 mL | 0.5889 mL | 1.4721 mL | |
| 40 mM | 0.0442 mL | 0.2208 mL | 0.4416 mL | 1.1041 mL | |
| 50 mM | 0.0353 mL | 0.1767 mL | 0.3533 mL | 0.8833 mL | |
| 60 mM | 0.0294 mL | 0.1472 mL | 0.2944 mL | 0.7361 mL | |
| 80 mM | 0.0221 mL | 0.1104 mL | 0.2208 mL | 0.5521 mL | |
| 100 mM | 0.0177 mL | 0.0883 mL | 0.1767 mL | 0.4416 mL |